Metastatic Hormone-Sensitive Prostate Cance

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Metastatic Hormone-Sensitive Prostate Cance trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingNot Applicable

NCT07154914

A Novel Insight Into CRPC Progression and Immune: Evidence From Single-cell Spatial Transcriptome Multi-omics

This study will follow patients with metastatic hormone-sensitive prostate cancer (mHSPC) who receive androgen deprivation therapy (ADT) combined with different…

Location not specified396 participantsStarted 2025-09-01

Treatment: Abiraterone + ADT